Vialife (ALVIA.PA) Stock Price

Vialife Price

Euronext·CLOSED
10.00EUR+0.00 (+0.00 %)
Market closed

Over the last 23 years Vialife grew revenue by 6.0% annually, reaching 4.43 M EUR. Earnings per share have grown at 3.0% per year over the last 22 years. For Vialife, the net margin of 2.1% is up versus -3.9% a few years ago. At today's price the dividend yield works out to roughly 2.38%. The payout ratio is around 99% of earnings. The stock trades about 2% above its 52-week low.

Vialife stock price

Volume
Ex-Dividend
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Vialife over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Vialife stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Vialife's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Vialife Stock Price History
DateVialife Price
7/22/202610.00 EUR
7/21/202610.00 EUR
7/20/202610.00 EUR
7/17/202610.00 EUR
7/16/202612.20 EUR
7/15/202612.20 EUR
7/14/202612.20 EUR
7/13/202612.20 EUR
7/10/202612.20 EUR
7/9/202612.20 EUR
7/8/202612.20 EUR
7/7/202612.20 EUR
7/6/202612.20 EUR
7/3/202612.20 EUR
7/2/202612.20 EUR
7/1/202612.20 EUR
6/30/202612.20 EUR
6/29/202612.20 EUR
6/26/202612.20 EUR
6/25/202612.20 EUR
6/24/202612.20 EUR
6/23/202612.20 EUR
6/22/202612.20 EUR
6/19/202612.20 EUR
6/18/202612.20 EUR
6/17/202612.20 EUR
6/16/202612.20 EUR
6/15/202612.20 EUR
6/12/202612.20 EUR
6/11/202612.20 EUR
6/10/202612.20 EUR
6/9/202612.20 EUR
6/8/202612.20 EUR
6/5/202612.20 EUR
6/4/202612.20 EUR
6/3/202612.20 EUR
6/2/202612.20 EUR
6/1/202612.20 EUR
5/29/202612.20 EUR
5/28/202612.20 EUR
5/27/202612.20 EUR
5/26/202612.20 EUR
5/25/202612.20 EUR
5/22/202612.20 EUR
5/21/202612.20 EUR
5/20/202612.20 EUR
5/19/202612.20 EUR
5/18/202612.20 EUR
5/15/202612.20 EUR
5/14/202612.20 EUR
5/13/202612.20 EUR
5/12/202612.20 EUR
5/11/202612.20 EUR
5/8/202612.20 EUR
5/7/202612.20 EUR
5/6/202612.20 EUR
5/5/202612.20 EUR
5/4/202612.20 EUR
4/30/202612.30 EUR
4/29/202612.30 EUR
4/28/202612.30 EUR
4/27/202612.30 EUR
4/24/202612.30 EUR
4/23/202612.30 EUR
4/22/202612.30 EUR
4/21/202612.30 EUR
4/20/202612.30 EUR
4/17/202612.30 EUR
4/16/202611.80 EUR
4/15/202611.80 EUR
4/14/202611.80 EUR
4/13/202611.80 EUR
4/10/202611.80 EUR
4/9/202610.90 EUR
4/8/202610.90 EUR
4/7/202610.90 EUR
4/2/202610.90 EUR
4/1/202610.90 EUR
3/31/202611.90 EUR
3/30/202611.90 EUR
3/27/202611.90 EUR
3/26/202611.90 EUR
3/25/202611.90 EUR
3/24/202612.30 EUR
3/23/202612.30 EUR
3/20/202612.30 EUR
3/19/202612.30 EUR
3/18/202612.30 EUR
3/17/202612.30 EUR
3/16/202612.30 EUR
3/13/202612.30 EUR
3/12/202612.30 EUR
3/11/202612.30 EUR
3/10/202612.30 EUR
3/9/202612.30 EUR
3/6/202612.30 EUR
3/5/202612.30 EUR
3/4/202612.30 EUR
3/3/202612.30 EUR
3/2/202612.30 EUR
2/27/202612.30 EUR
2/26/202612.30 EUR
2/25/202612.30 EUR
2/24/202612.30 EUR
2/23/202612.30 EUR
2/20/202612.30 EUR
2/19/202612.30 EUR
2/18/202612.30 EUR
2/17/202612.30 EUR
2/16/202612.30 EUR
2/13/202612.30 EUR
2/12/202612.30 EUR
2/11/202612.30 EUR
2/10/202612.30 EUR
2/9/202612.30 EUR
2/6/202612.30 EUR
2/5/202612.30 EUR
2/4/202612.30 EUR
2/3/202612.30 EUR
2/2/202612.30 EUR
1/30/202612.30 EUR
1/29/202612.30 EUR
1/28/20269.85 EUR
1/27/202612.30 EUR
1/26/202611.50 EUR
1/23/202611.50 EUR
1/22/202611.50 EUR
1/21/202611.50 EUR
1/20/202611.50 EUR
1/19/202611.50 EUR
1/16/202611.50 EUR
1/15/202611.90 EUR
1/14/202611.90 EUR
1/13/202611.90 EUR
1/12/202611.70 EUR
1/9/202611.70 EUR
1/8/202611.70 EUR
1/7/202612.10 EUR
1/6/202612.10 EUR
1/5/202611.70 EUR
1/2/202611.70 EUR
12/31/202511.70 EUR
12/30/202511.70 EUR
12/29/202511.70 EUR
12/24/202511.70 EUR
12/23/202511.70 EUR
12/22/202511.70 EUR
12/19/202511.60 EUR
12/18/202511.70 EUR
12/17/202511.90 EUR
12/16/202511.90 EUR
12/15/202511.90 EUR
12/12/202511.90 EUR
12/11/202511.90 EUR
12/10/202512.00 EUR
12/9/202512.00 EUR
12/8/202510.00 EUR
12/5/202512.10 EUR
12/4/202512.10 EUR
12/3/202510.90 EUR
12/2/202510.90 EUR
12/1/202512.00 EUR
11/28/202512.00 EUR
11/27/202512.00 EUR
11/26/202512.00 EUR
11/25/202512.00 EUR
11/24/202512.00 EUR
11/21/202512.00 EUR
11/20/202512.00 EUR
11/19/202512.00 EUR
11/18/202512.00 EUR
11/17/202512.00 EUR
11/14/202512.00 EUR
11/13/202512.00 EUR
11/12/202512.00 EUR
11/11/202512.00 EUR
11/10/202512.00 EUR
11/7/202512.00 EUR
11/6/202512.00 EUR
11/5/202512.00 EUR
11/4/202512.00 EUR
11/3/202512.40 EUR
10/31/202512.40 EUR
10/30/202512.40 EUR
10/29/202512.40 EUR
10/28/202512.40 EUR
10/27/202512.40 EUR
10/24/202512.40 EUR
10/23/202512.40 EUR
10/22/202512.40 EUR
10/21/202512.40 EUR
10/20/202513.20 EUR
10/17/202513.20 EUR
10/16/202513.20 EUR
10/15/202513.20 EUR
10/14/202513.20 EUR
10/13/202513.20 EUR
10/10/202513.20 EUR
10/9/202513.20 EUR
10/8/202513.20 EUR
10/7/202513.20 EUR
10/6/202513.20 EUR
10/3/202513.20 EUR
10/2/202512.50 EUR
10/1/202512.50 EUR
9/30/202512.50 EUR
9/29/202512.50 EUR
9/26/202512.50 EUR
9/25/202512.50 EUR
9/24/202512.50 EUR
9/23/202512.50 EUR
9/22/202512.50 EUR
9/19/202512.50 EUR
9/18/202512.50 EUR
9/17/202512.50 EUR
9/16/202512.50 EUR
9/15/202512.50 EUR
9/12/202512.50 EUR
9/11/202512.50 EUR
9/10/202512.50 EUR
9/9/202512.50 EUR
9/8/202512.70 EUR
9/5/202512.80 EUR
9/4/202512.80 EUR
9/3/202512.80 EUR
9/2/202512.80 EUR
9/1/202512.80 EUR
8/29/202512.80 EUR
8/28/202512.80 EUR
8/27/202512.80 EUR
8/26/202512.80 EUR
8/25/202512.80 EUR
8/22/202512.80 EUR
8/21/202512.80 EUR
8/20/202512.80 EUR
8/19/202512.80 EUR
8/18/202512.80 EUR
8/15/202512.80 EUR
8/14/202512.80 EUR
8/13/202512.80 EUR
8/12/202512.80 EUR
8/11/202512.80 EUR
8/8/202512.90 EUR
8/7/202512.90 EUR
8/6/202512.90 EUR
8/5/202512.90 EUR
8/4/202513.20 EUR
8/1/202513.20 EUR
7/31/202513.20 EUR
7/30/202513.20 EUR
7/29/202513.20 EUR
7/28/202513.20 EUR
7/25/202513.20 EUR
Access this data via the Eulerpool API
Get Free API Key

Vialife Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2015
10.00 M EUR
1.18 M EUR
824,000.00 EUR
Jan 1, 2016
5.33 M EUR
1.75 M EUR
1.14 M EUR
Jan 1, 2017
4.71 M EUR
-135,600.00 EUR
-46,200.00 EUR
Jan 1, 2018
4.36 M EUR
-457,100.00 EUR
-168,600.00 EUR
Jan 1, 2022
4.51 M EUR
-6,700.00 EUR
-200,100.00 EUR
Jan 1, 2023
4.32 M EUR
70,900.00 EUR
123,200.00 EUR
Jan 1, 2024
4.53 M EUR
358,800.00 EUR
341,100.00 EUR
Jan 1, 2025
4.43 M EUR
42,700.00 EUR
95,200.00 EUR

Vialife Income Statement, Balance Sheet, Cash Flow Statement

Last updated Jul 25, 2026, 5:11 AM
 
REVENUEM EUR
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEM EUR
EBITk EUR
EBIT MARGIN%
NET INCOMEk EUR
DIV.EUR
DIV. GROWTH%
SHARESk
2004200520062007200820092012201420152016201720182022202320242025
2.001.002.003.003.004.005.006.0010.005.004.004.004.004.004.004.00
100.00-50.00100.0050.00–33.3325.0020.0066.67-50.00-20.00–––––
50.00100.0050.0066.6733.3350.0040.0050.0050.0040.0025.0025.0025.0025.0025.0025.00
1.001.001.002.001.002.002.003.005.002.001.001.001.001.001.001.00
––––––––1,000.001,000.00––––––
––––––––10.0020.00––––––
–––––––––1,000.00––––––
–––––0.501.08–1.912.132.13–3.13–1.000.24
––––––114.00––11.52–––––-76.00
400.00400.00400.00400.00400.00400.00400.00400.00400.00400.00400.00400.00395.90395.90395.90395.90
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Vialife generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Vialife retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Vialife's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Vialife has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Vialife's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Vialife stock margins

The Vialife margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Vialife. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Vialife.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2015
59.95 %
11.84 %
8.24 %
Jan 1, 2016
49.27 %
32.72 %
21.32 %
Jan 1, 2017
42.01 %
-2.88 %
-0.98 %
Jan 1, 2018
37.11 %
-10.48 %
-3.86 %
Jan 1, 2022
37.11 %
-0.15 %
-4.44 %
Jan 1, 2023
37.11 %
1.64 %
2.85 %
Jan 1, 2024
37.11 %
7.93 %
7.54 %
Jan 1, 2025
37.11 %
0.96 %
2.15 %

Vialife Stock Revenue, EBIT, Earnings per Share

The Vialife earnings per share therefore indicates how much revenue Vialife has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2015
25.00 EUR
2.96 EUR
2.06 EUR
Jan 1, 2016
13.33 EUR
4.36 EUR
2.84 EUR
Jan 1, 2017
11.77 EUR
-0.34 EUR
-0.12 EUR
Jan 1, 2018
10.91 EUR
-1.14 EUR
-0.42 EUR
Jan 1, 2022
11.39 EUR
-0.02 EUR
-0.51 EUR
Jan 1, 2023
10.92 EUR
0.18 EUR
0.31 EUR
Jan 1, 2024
11.43 EUR
0.91 EUR
0.86 EUR
Jan 1, 2025
11.20 EUR
0.11 EUR
0.24 EUR

Vialife business model & stock analysis

Vialife SA is a company specializing in the manufacture and distribution of nutritional supplements. It was founded in 2001 and is based in Switzerland. The founder, Michel Vonlanthen, had previous experience in the production of nutritional supplements and decided to start his own company. Vialife SA's business model focuses on producing and distributing supplements based on natural ingredients. The company places emphasis on quality and effectiveness, offering a wide range of products tailored to individual customer needs. Their main sectors include sports nutrition and healthcare. Sustainability is also a key concern for Vialife SA, with all ingredients sourced from environmentally and socially responsible production. They work closely with research institutions and laboratories to ensure product quality and continue to invest in product development and employee training. Vialife SA is known for its high quality, customer-oriented approach, and sustainability, making it a key player in the nutritional supplement market.

Vialife SWOT Analysis

Strengths

Vialife SA has several key strengths that contribute to its success:

  • Strong market presence and brand reputation in the healthcare industry.
  • Extensive range of high-quality products offering innovative solutions.
  • Established distribution network and partnerships with leading healthcare providers.
  • Robust financial position and high profitability.
  • Well-experienced and competent management team.

Despite its strengths, Vialife SA faces certain weaknesses that need to be addressed:

  • Limited geographical presence, primarily focused on domestic market.
  • Relatively high prices compared to some competitors.
  • Dependence on a few key suppliers for raw materials.
  • Lack of diversification in product offerings.
  • Some outdated manufacturing facilities leading to higher production costs.

Vialife SA can leverage the following opportunities to further grow and expand:

  • Increasing demand for healthcare products and services globally.
  • Emerging markets with untapped potential for expansion.
  • Rapid advancements in healthcare technology, providing new product development possibilities.
  • Growing consumer awareness and demand for eco-friendly and sustainable healthcare solutions.
  • Partnerships and collaborations with research institutions and healthcare organizations.

Vialife SA should be cautious about the following potential threats in the healthcare industry:

  • Intense competition from domestic and international healthcare companies.
  • Economic downturns and fluctuations impacting consumer spending on healthcare.
  • Stringent regulatory requirements and compliance challenges.
  • Vulnerability to supply chain disruptions.
  • Shifting customer preferences and evolving market trends.

Weaknesses

Despite its strengths, Vialife SA faces certain weaknesses that need to be addressed:

  • Limited geographical presence, primarily focused on domestic market.
  • Relatively high prices compared to some competitors.
  • Dependence on a few key suppliers for raw materials.
  • Lack of diversification in product offerings.
  • Some outdated manufacturing facilities leading to higher production costs.

Vialife SA can leverage the following opportunities to further grow and expand:

  • Increasing demand for healthcare products and services globally.
  • Emerging markets with untapped potential for expansion.
  • Rapid advancements in healthcare technology, providing new product development possibilities.
  • Growing consumer awareness and demand for eco-friendly and sustainable healthcare solutions.
  • Partnerships and collaborations with research institutions and healthcare organizations.

Vialife SA should be cautious about the following potential threats in the healthcare industry:

  • Intense competition from domestic and international healthcare companies.
  • Economic downturns and fluctuations impacting consumer spending on healthcare.
  • Stringent regulatory requirements and compliance challenges.
  • Vulnerability to supply chain disruptions.
  • Shifting customer preferences and evolving market trends.

Opportunities

Vialife SA can leverage the following opportunities to further grow and expand:

  • Increasing demand for healthcare products and services globally.
  • Emerging markets with untapped potential for expansion.
  • Rapid advancements in healthcare technology, providing new product development possibilities.
  • Growing consumer awareness and demand for eco-friendly and sustainable healthcare solutions.
  • Partnerships and collaborations with research institutions and healthcare organizations.

Vialife SA should be cautious about the following potential threats in the healthcare industry:

  • Intense competition from domestic and international healthcare companies.
  • Economic downturns and fluctuations impacting consumer spending on healthcare.
  • Stringent regulatory requirements and compliance challenges.
  • Vulnerability to supply chain disruptions.
  • Shifting customer preferences and evolving market trends.

Threats

Vialife SA should be cautious about the following potential threats in the healthcare industry:

  • Intense competition from domestic and international healthcare companies.
  • Economic downturns and fluctuations impacting consumer spending on healthcare.
  • Stringent regulatory requirements and compliance challenges.
  • Vulnerability to supply chain disruptions.
  • Shifting customer preferences and evolving market trends.

Vialife Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Vialife historical P/E ratio, EBIT multiple, and P/S ratio

Vialife annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Vialife shares outstanding

The number of shares of Vialife was 395,900 in 2025. This indicates how many shares Vialife is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2015
400,000.00 Stocks
Jan 1, 2016
400,000.00 Stocks
Jan 1, 2017
400,000.00 Stocks
Jan 1, 2018
400,000.00 Stocks
Jan 1, 2022
395,900.00 Stocks
Jan 1, 2023
395,900.00 Stocks
Jan 1, 2024
395,900.00 Stocks
Jan 1, 2025
395,900.00 Stocks

Vialife Dividend History

13 years of dividend payments

YearAnnual DividendYoY ChangePayments
20250.24EUR↓ 76.3%1×
Sep 18, 20250.24EUR↓ 76.3%1/1
20241.00EUR↓ 68.1%1×
20223.13EUR↑ 92.0%—
20211.63EUR↑ 117.3%1×
20200.75EUR 0.0%1×
20190.75EUR↓ 64.8%1×
20172.13EUR 0.0%—
20162.13EUR↑ 11.5%1×
20151.91EUR↑ 77.7%1×
20121.08EUR↑ 168.7%1×

Vialife dividend history and estimates

In 2025, Vialife paid a dividend amounting to 0.24 EUR. Dividend means that Vialife distributes a portion of its profits to its owners.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details
Date
Dividend
Dividend (Estimate)
Jan 1, 2009
0.50 EUR
0.00 EUR
Jan 1, 2012
1.08 EUR
0.00 EUR
Jan 1, 2015 (e)
0.00 EUR
1.91 EUR
Jan 1, 2016
2.13 EUR
0.00 EUR
Jan 1, 2017
2.13 EUR
0.00 EUR
Jan 1, 2022
3.13 EUR
0.00 EUR
Jan 1, 2024 (e)
0.00 EUR
1.00 EUR
Jan 1, 2025
0.24 EUR
0.00 EUR

Vialife dividend payout ratio

In 2025, Vialife had a payout ratio of 98.75%. The payout ratio indicates the percentage of the company's profits that Vialife distributes as dividends.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2015
92.71 %
Jan 1, 2016
74.93 %
Jan 1, 2017
96.59 %
Jan 1, 2018
103.81 %
Jan 1, 2022
106.21 %
Jan 1, 2023
107.01 %
Jan 1, 2024
116.08 %
Jan 1, 2025
98.75 %
Price targets and forecasts for Vialife are not yet available.

Vialife shareholder structure

% Name
50.90000%
Mareine (Vincent)
Mareine (Vincent)
30.90000%
Bonin (Maxime)
Bonin (Maxime)

Vialife Executives and Management Board

VM

Vincent Mareine

(45)

Chairman of the Board, Chief Executive Officer

MB

Maxime Bonin

(45)

Deputy Chief Executive Officer, Director

PG

Philippe Guilloux

Administrative and Financial Director

MF

Marc De Fougerolles

Director of Sales

AC

Ms. Anne-Marie Couderc

(64)

Director

Frequently asked questions about Vialife

The business model of Vialife SA revolves around developing and manufacturing innovative pharmaceutical products. Vialife SA focuses on conducting extensive research and invests in cutting-edge technologies to produce high-quality medications that address various medical needs. Through strategic partnerships with healthcare professionals, Vialife SA aims to improve patient outcomes and well-being. The company's business model also encompasses actively collaborating with regulatory bodies to ensure compliance and facilitate the global distribution of their products. With a strong commitment to innovation and patient-centric approach, Vialife SA continues to strive for excellence in the pharmaceutical industry.

All fundamentals and in-depth analysis of Vialife

Our stock analysis for Vialife stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Vialife. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Vialife Stock
Vialife Revenue→
Vialife Stock
Vialife Net Income→
Vialife Stock
Vialife P/E→
Vialife Stock
Vialife P/S→
Vialife Stock
Vialife EBIT→
Vialife Stock
Vialife Dividend→
Vialife Stock
Vialife Directors Dealings→
Vialife Stock
Vialife Stocks→
Vialife Stock
Vialife Market capitalization→
Vialife Stock
Vialife Debt→
Vialife Stock
Vialife Liabilities→
Vialife Stock
Vialife Equity→
Vialife Stock
Vialife AAQS→
Vialife Stock
Vialife Employees→
Vialife Stock
Vialife ROE→
Vialife Stock
Vialife ROA→
Vialife Stock
Vialife ROCE→
Vialife Stock
Vialife News→
Vialife Stock
Vialife Analyst Price Targets→

Cyclical consumption Stocks

Viaz TyresVIA HoldingsVibra EnergiaVFViceroy HotelsVeste SA EstiloVictoria's Secret &VestandVictorian Plumbing GroupVery Good Tour CoVidendumVertu MotorsAll Stocks A–Z →